Picture of Allena Pharmaceuticals logo

ALNAQ — Allena Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Allena Pharmaceuticals reports third quarter results

Nov 7 (Reuters) - Allena Pharmaceuticals Inc  ALNA.O :
    * ALLENA PHARMACEUTICALS REPORTS THIRD QUARTER 2018
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
    * Q3 LOSS PER SHARE $0.46
    * Q3 EARNINGS PER SHARE VIEW $-0.47 -- THOMSON REUTERS
I/B/E/S
    * AS OF SEPTEMBER 30, 2018, CASH AND CASH EQUIVALENTS WERE
$70.6
MILLION
    * EXPECTS EXISTING CASH AND CASH EQUIVALENTS WILL BE
SUFFICIENT TO
FUND OPERATING EXPENSES, CAPITAL REQUIREMENTS INTO 2020

Source text for Eikon:  ID:nGNX8xcrh3 
Further company coverage:  ALNA.O 

 ((Briefs@thomsonreuters.com;))

Recent news on Allena Pharmaceuticals

See all news